These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38582018)

  • 1. Early-onset levodopa responsive parkinsonism in PPP2R5D mutation.
    Mahale R; Arunachal G; Chadha D; Padmanabha H; M P; Pavagada M
    Parkinsonism Relat Disord; 2024 Jun; 123():106952. PubMed ID: 38582018
    [No Abstract]   [Full Text] [Related]  

  • 2. Early-onset parkinsonism in PPP2R5D-related neurodevelopmental disorder.
    Hetzelt KLML; Kerling F; Kraus C; Rauch C; Thiel CT; Winterholler M; Reis A; Zweier C
    Eur J Med Genet; 2021 Jan; 64(1):104123. PubMed ID: 33338668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome.
    Rauschendorf MA; Jost M; Stock F; Zimmer A; Rösler B; Rijntjes M; Piroth T; Coenen VA; Reinacher PC; Meyer PT; Frings L; Weiller C; Fischer J; Klebe S
    Mov Disord; 2017 Mar; 32(3):478-480. PubMed ID: 27869329
    [No Abstract]   [Full Text] [Related]  

  • 4. Early-Onset Parkinsonism Is a Manifestation of the PPP2R5D p.E200K Mutation.
    Kim CY; Wirth T; Hubsch C; Németh AH; Okur V; Anheim M; Drouot N; Tranchant C; Rudolf G; Chelly J; Tatton-Brown K; Blauwendraat C; Vonsattel JPG; Cortes E; Alcalay RN; Chung WK
    Ann Neurol; 2020 Nov; 88(5):1028-1033. PubMed ID: 32743835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPP2R5D heterozygous pathogenic variant causes early-onset parkinsonism and treatment implications: A case report.
    Yau WY; Vijayan S; Ravenscroft G
    Parkinsonism Relat Disord; 2024 Jul; 124():106976. PubMed ID: 38718479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decades of delayed diagnosis in 4 levodopa-responsive young-onset monogenetic parkinsonism patients.
    Ling H; Braschinsky M; Taba P; Lüüs SM; Doherty K; Hotter A; Poewe W; Lees AJ
    Mov Disord; 2011 Jun; 26(7):1337-40. PubMed ID: 21449012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partially Levodopa-Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant.
    Usnich T; Becker LF; Nagel I; Bäumer T; Münchau A
    Mov Disord Clin Pract; 2024 Jun; 11(6):749-750. PubMed ID: 38586890
    [No Abstract]   [Full Text] [Related]  

  • 8. SCA2 presenting as levodopa-responsive parkinsonism in a young patient from the United Kingdom: a case report.
    Wilkins A; Brown JM; Barker RA
    Mov Disord; 2004 May; 19(5):593-5. PubMed ID: 15133829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa responsive Parkinsonism in adults with Angelman Syndrome.
    Harbord M
    J Clin Neurosci; 2001 Sep; 8(5):421-2. PubMed ID: 11535008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to: Partially Levodopa-Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant.
    Nardecchia F; Martinelli S; Pollini L; Leuzzi V
    Mov Disord Clin Pract; 2024 Jun; 11(6):751-752. PubMed ID: 38616337
    [No Abstract]   [Full Text] [Related]  

  • 11. Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.
    Infante J; Berciano J; Volpini V; Corral J; Polo JM; Pascual J; Combarros O
    Mov Disord; 2004 Jul; 19(7):848-852. PubMed ID: 15254952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New nonsense mutation in the GTP-cyclohydrolase I gene in L-DOPA responsive dystonia-parkinsonism.
    Hoenicka J; Vidal L; Godoy M; Ochoa JJ; García de Yébenes J
    Mov Disord; 2001 Mar; 16(2):364-6. PubMed ID: 11295799
    [No Abstract]   [Full Text] [Related]  

  • 13. Two large Polish kindreds with levodopa-responsive Parkinsonism not linked to known Parkinsonian genes and loci.
    Krygowska-Wajs A; Hussey JM; Hulihan M; Farrer MJ; Tsuboi Y; Uitti RJ; Wszolek ZK
    Parkinsonism Relat Disord; 2003 Mar; 9(4):193-200. PubMed ID: 12618053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNAJC12 and dopa-responsive nonprogressive parkinsonism.
    Straniero L; Guella I; Cilia R; Parkkinen L; Rimoldi V; Young A; Asselta R; Soldà G; Sossi V; Stoessl AJ; Priori A; Nishioka K; Hattori N; Follett J; Rajput A; Blau N; Pezzoli G; Farrer MJ; Goldwurm S; Rajput AH; Duga S
    Ann Neurol; 2017 Oct; 82(4):640-646. PubMed ID: 28892570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa-responsive Parkinsonism following bilateral putaminal hemorrhages.
    Hatano T; Kubo S; Niijima-Ishii Y; Hattori N; Sugita Y
    Parkinsonism Relat Disord; 2013 Apr; 19(4):477-9. PubMed ID: 23182604
    [No Abstract]   [Full Text] [Related]  

  • 16. Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections.
    Diepold K; Schütz B; Rostasy K; Wilken B; Hougaard P; Güttler F; Romstad A; Birk Møller L
    Mov Disord; 2005 Jun; 20(6):764-7. PubMed ID: 15747353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced parkinsonism responsive to levodopa: an underrecognized entity.
    Chuang C; Constantino A; Balmaceda C; Eidelberg D; Frucht SJ
    Mov Disord; 2003 Mar; 18(3):328-331. PubMed ID: 12621638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.
    Quadri M; Fang M; Picillo M; Olgiati S; Breedveld GJ; Graafland J; Wu B; Xu F; Erro R; Amboni M; Pappatà S; Quarantelli M; Annesi G; Quattrone A; Chien HF; Barbosa ER; ; Oostra BA; Barone P; Wang J; Bonifati V
    Hum Mutat; 2013 Sep; 34(9):1208-15. PubMed ID: 23804577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCA2 may present as levodopa-responsive parkinsonism.
    Payami H; Nutt J; Gancher S; Bird T; McNeal MG; Seltzer WK; Hussey J; Lockhart P; Gwinn-Hardy K; Singleton AA; Singleton AB; Hardy J; Farrer M
    Mov Disord; 2003 Apr; 18(4):425-9. PubMed ID: 12671950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic asymmetric tremor and levodopa-responsive parkinsonism due to a vein of Galen aneurysmal malformation.
    de Souza A; Fernandes YS; Bhatkar SR; Bhonsle SK
    Parkinsonism Relat Disord; 2017 Oct; 43():122-123. PubMed ID: 28729088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.